HSBC Holdings’s Prelude Therapeutics PRLD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$13.9K Sell
17,411
-3,219
-16% -$2.58K ﹤0.01% 2512
2025
Q1
$17.5K Sell
20,630
-10
-0% -$9 ﹤0.01% 2516
2024
Q4
$25.6K Sell
20,640
-132
-0.6% -$164 ﹤0.01% 2601
2024
Q3
$43.8K Sell
20,772
-4,133
-17% -$8.72K ﹤0.01% 2501
2024
Q2
$90.7K Hold
24,905
﹤0.01% 2380
2024
Q1
$118K Buy
24,905
+1,695
+7% +$8.03K ﹤0.01% 2400
2023
Q4
$93.8K Buy
23,210
+12
+0.1% +$48 ﹤0.01% 2132
2023
Q3
$70.8K Buy
+23,198
New +$70.8K ﹤0.01% 2088